THIRD NATURE
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Jan 2024)
What this means for you
This application is over — abandoned 15 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97603953
- Mark type
- Stylized text
- Filed
- 23 Sept 2022
- Published for opposition
- 18 Apr 2023
- Abandoned
- 15 Jan 2024
- Attorney of record
- Arrielle S. Siolos
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable mobile application software platform for advising about and providing information through experts in the field of hormonal health
- Class 035 — Advertising and business services: Provision of an online marketplace for selling hormonal health preparations
- Class 041 — Education and entertainment services: Online journals, namely, blogs featuring information on hormonal health
- Class 042 — Scientific and technological services: Digital webstie, namely, providing temporary use of online non-downloadable software for offering advice and information in the field of hormonal health
Owner
- GlaxoSmithKline Consumer Healthcare (UK) IP Limited, Brentford, Middlesex, GB
- GlaxoSmithKline Consumer Healthcare (UK) IP Limited, Brentford, Middlesex, GB
Prosecution history
- 16 Jan 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Jan 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Jun 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Apr 2023 — PUBLISHED FOR OPPOSITION
- 29 Mar 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Mar 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Mar 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Mar 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Mar 2023 — NON-FINAL ACTION E-MAILED
- 08 Mar 2023 — NON-FINAL ACTION WRITTEN
- 07 Mar 2023 — ASSIGNED TO EXAMINER
- 17 Oct 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED